VF
GYRE icon

Virtu Financial’s Gyre Therapeutics GYRE Stock Holding History

Virtu Financial’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,242
Closed -$17K – 1535
2023
Q2 		$17K Buy
+3,242
New +$11.6K ﹤0.01% 1288
2023
Q1 		– Sell
-17,496
Closed -$69K – 1738
2022
Q4 		$69K Sell
17,496
-7,727
-31% -$31.5K 0.01% 1025
2022
Q3 		$95K Buy
25,223
+18,026
+250% +$229K 0.01% 1095
2022
Q2 		$96K Buy
+7,197
New +$47.8K 0.01% 963
2022
Q1 		– Sell
-6,325
Closed -$43K – 1702
2021
Q4 		$43K Buy
6,325
+2,445
+63% +$41.8K ﹤0.01% 1370
2021
Q3 		$120K Buy
+3,880
New +$128K 0.01% 1077
2018
Q2 		– Sell
-2,933
Closed -$568K – 2184
2018
Q1 		$568K Buy
+2,933
New +$547K 0.03% 643

Other funds holding GYRE

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

Virtu Financial's GYRE Position: Q3 2023 in Review

Virtu Financial sold out of Gyre Therapeutics (GYRE) in Q3 2023, closing a stake of 3,242 shares — an estimated $17K sold.

Virtu Financial first reported a position in GYRE in Q1 2018 and held it in 7 quarters. The position peaked at $568K in Q1 2018. 31 funds tracked by Wall St. Rank hold GYRE as of Q3 2023.

  • Virtu Financial reported no remaining Gyre Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Virtu Financial sold 3,242 Gyre Therapeutics shares in Q3 2023, an estimated $17K.
  • Virtu Financial first reported a position in Gyre Therapeutics in Q1 2018 and held it in 7 quarters.
  • Virtu Financial's Gyre Therapeutics position peaked at $568K in Q1 2018.
  • 31 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q3 2023.

Based on Virtu Financial's 13F filing for Q3 2023, filed 15 Nov 2023.